|
| Reference | Age/sex | Arthritis | Concomitant autoimmune disease | Prior or concomitant immunosuppressant use | Radiological finding | Pathology |
|
| Kaplan and Waite [12] | 70/M | No | No | MTX | Interstitial fibrosis with honeycombing | Not specified |
|
| Guzman [10] | 54/M | Yes | No | A variety of anti-inflammatory drugs | Considerable loss of volume in both upper lobes with advanced fibrosis | Notable interstitial fibrosis with dilated bronchi and bronchioles |
|
| Hiki et al. [13] | 23/M | Yes | IgA nephropathy | No | A reticular or reticulonodular pattern with bilateral pneumonic consolidation | Severe interstitial pneumonia |
|
| Salaffi et al. [14] | 62/M | Yes | No | Gold salts, etretinate, sulfasalazine, MTX | Bilateral and diffuse interstitial infiltrates, broader in the upper right lobe | Not specified |
|
| Kawakami et al. [15] | 50/F | No | Polymyalgia rheumatic | Not specified | Bilateral basilar reticulonodular shadows | NSIP |
|
| Ameen et al. [16] | 53/F | No | No | MTX, cyclosporin | Widespread changes in the mid- and upper zones with thickening and nodularity of the interlobular septae | Not specified |
|
| Woltsche et al. [17] | 78/M | Yes | No | Sulfasalazine | Small nodular densities over both lungs | Lymphoplasmocytic interstitial infiltration |
|
| Manero Ruiz et al. [18] | Not specified | Yes | No | Gold salts | Not specified | Not specified |
|
| Tokunaga et al. [19] | 56/M | No | No | Sho-saiko-to (Chinese herbs) | Microcystic lesions, reticular shadows, and traction bronchiectasis underneath the pleura at the back of both lower lobes | UIP |
|
| Abou-Samra et al. [20] | 35/F | No | No | MTX, cyclosporin, acitretin | Bilateral interstitial infiltrate and alveolar filling of the right pulmonary base | Not specified |
|
| Abou-Samra et al. [20] | 61/F | No | No | Acitretin, MTX | Bilateral interstitial infiltrate of the pulmonary bases | Not specified |
|
| Messina et al. [21] | 63/F | No | No | No | Diffuse interstitial infiltrates | Obliteration of the alveolar spaces connective tissue |
|
| El-Hag et al. [22] | Not specified | No | No | Infliximab, azathioprine | Not specified | Not specified |
|
| Penizzotto et al. [23] | 51/F | No | No | Not specified | Not specified | Not specified |
|
| Lee and Hutchinson [24] | 52/F | Yes | No | MTX, leflunomide, sulfasalazine | Ground glass appearance throughout the lung fields | Not specified |
|
| Deegan et al. [25] | 49/M | No | No | Fumaric acid esters | Bilateral, mostly peripheral foci of consolidation with air bronchograms | Pattern of organizing pneumonia |
|
| Leger et al. [26] | 68/F | No | No | Infliximab | Bilateral basal interstitial infiltrates with pleural effusion | Not specified |
|
| Bale and Chee [27] | 67/M | No | No | Infliximab | Patchy alveolar and ground glass infiltrates | Not specified |
| Kakavas et al. [28] | 64/M | No | No | Infliximab | Bilateral ground glass and interstitial infiltrates | Not specified |
|
| Gupta and Espiritu [29] | 43/F | No | No | No | NSIP pattern | Not specified |
|
| Miyachi et al. [30] | 71/F | No | No | Etretinate, cyclosporin, methotrexate | Basal interstitial ground glass opacities | Not specified |
|
| Deng et al. [31] | 30/F | Yes | Rheumatoid arthritis | Prednisone, iguratimod, total glucosides of peony | Not specified | Not specified |
|
